Amrutanjan Health Care Stock Screener | Share Price & Fundamental Analysis
AMRUTANJAN
Pharmaceuticals
Share Price NSE
₹525.25
▼
-11.20 (-2.09%)
Share Price BSE
₹525.20
▼
-9.75 (-1.82%)
As of April 13, 2026, the Amrutanjan Health Care share price (NSE: AMRUTANJAN) is ₹525.25 on NSE and ₹525.20 on BSE, down 2.09% from the previous close, with shares trading between ₹521.00 and ₹538.00, and a 52-week range of ₹493.65–₹767.65.
Browse Amrutanjan Health Care financial data to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Amrutanjan Health Care Market Cap
₹1,550.91 Cr.
AMRUTANJAN P/E Ratio (TTM)
-
Amrutanjan Health Care P/B Ratio
4.48
EPS (TTM)
₹14.08
Dividend Yield
0.87%
Debt to Equity
0.02
AMRUTANJAN 52 Week High
₹767.65
Amrutanjan Health Care 52 Week Low
₹493.65
Operating Margin
-
Profit Margin
-
AMRUTANJAN Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹140.00
Total Equity
₹109.00
Amrutanjan Health Care Share Price History - Stock Screener Chart
Screen AMRUTANJAN historical share price movements with interactive charts. Analyze price trends and patterns.
Amrutanjan Health Care Company Profile - Fundamental Screener
Screen Amrutanjan Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AMRUTANJAN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE098F01031
Amrutanjan Health Care Balance Sheet Screener
Screen AMRUTANJAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2016 | 2015 |
|---|---|---|
| Assets | ||
| Total Assets | 140 | 124 |
| Current Assets | 101 | 83 |
| Fixed Assets | 29 | 24 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 4 | 3 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 109 | 95 |
| Share Capital | 3 | 3 |
| Reserves & Surplus | 106 | 92 |
Amrutanjan Health Care Income Statement Screener - Profit & Revenue Analysis
Screen Amrutanjan Health Care income statement and profit fundamentals.
Analyze AMRUTANJAN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Amrutanjan Health Care share price evaluation.
| Item | None-None | 2016-March | 2015-March |
|---|---|---|---|
| Revenue | 0 | 192 | 171 |
| Expenses | 0 | 156 | 143 |
| EBITDA | 0 | 37 | 28 |
| Operating Profit % | 0.00% | 16.00% | 14.00% |
| Depreciation | 0 | 3 | 3 |
| Interest | 0 | 0 | 1 |
| Profit Before Tax | 0 | 32 | 24 |
| Tax | 0 | 12 | 9 |
| Net Profit | 0 | 21 | 15 |
| EPS | 0.00 | 14.08 | 10.31 |
Amrutanjan Health Care Cash Flow Screener - Liquidity Fundamentals
Screen AMRUTANJAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2016-March | 2015-March |
|---|---|---|
| Operating Activities | 21 | 18 |
| Investing Activities | 4 | -5 |
| Financing Activities | -13 | -12 |
| Net Cash Flow | 12 | 2 |
Amrutanjan Health Care Shareholding Pattern Screener
See Amrutanjan Health Care shareholding pattern with promoter, FII, and DII holdings.
Check Amrutanjan Health Care promoter holding and ownership changes for AMRUTANJAN on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 50.59% | 50.59% |
| FII Holding | 2.27% | 2.38% | 2.41% | 2.30% | 2.30% | 2.34% | 1.55% | 1.38% |
| DII Holding | 13.00% | 12.90% | 12.70% | 11.41% | 11.12% | 10.60% | 7.32% | 7.29% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.09% | 32.18% | 32.28% | 33.56% | 33.73% | 34.09% | 33.87% | 34.17% |
| Other Holding | 6.13% | 6.02% | 6.09% | 6.22% | 6.33% | 6.45% | 6.67% | 6.57% |
| Shareholder Count | 46,675 | 47,954 | 49,431 | 51,674 | 53,856 | 54,536 | 57,169 | 62,664 |
Amrutanjan Health Care Share Dividend Screener - Share Yield Analysis
Check Amrutanjan Health Care dividend history with payout and yield data.
View Amrutanjan Health Care dividend details including ex-dates and amounts for AMRUTANJAN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹4.60 | 0.93% |
| 2024-March | ₹4.60 | 0.71% |
| 2023-March | ₹4.60 | 0.74% |
| 2022-March | ₹4.60 | 0.80% |
| 2021-March | ₹4.20 | 0.53% |
| 2020-March | ₹2.10 | 0.37% |
| 2019-March | ₹2.15 | 0.65% |
| 2018-March | ₹3.05 | 0.99% |
| 2017-March | ₹3.85 | 1.42% |
Amrutanjan Health Care Stock Index Membership
See which indices include Amrutanjan Health Care stock.
Check AMRUTANJAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Amrutanjan Health Care Market Events Screener - Corporate Actions
Get Amrutanjan Health Care corporate actions including splits, bonuses, and buybacks.
Check Amrutanjan Health Care stock events that may affect AMRUTANJAN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 2.60 /share | 4.98% | ||
| Dividend | ₹ 2.60 /share | -8.04% | ||
| Annual General Meeting | NA | 15.67% | ||
| Dividend | ₹ 2.60 /share | 6.32% | ||
| Dividend | ₹ 2.60 /share | -11.22% | ||
| Annual General Meeting | NA | -5.75% | ||
| Annual General Meeting | NA | 5.89% | ||
| Dividend | ₹ 2.60 /share | 7.69% | ||
| Annual General Meeting | NA | -2.94% | ||
| 2026-02-06 | 2026-02-07 | Dividend | ₹ 1.00 /share | 10.34% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | -2.77% |
| 2025-11-18 | 2025-11-18 | Dividend | ₹ 1.00 /share | 0.36% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -1.32% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -4.43% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 5.45% |
Amrutanjan Health Care Competitors Screener - Peer Comparison
Screen AMRUTANJAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 397,066 | 37.62 | 54,729 | 9.71% | 10,980 | 34.03 |
| Divis Laboratories | 162,374 | 63.80 | 9,712 | 18.67% | 2,191 | 53.67 |
| Torrent Pharmaceuticals | 140,631 | 60.97 | 11,539 | 6.99% | 1,911 | 47.83 |
| Lupin | 106,665 | 22.48 | 22,910 | 13.74% | 3,306 | 57.51 |
| Dr Reddys Laboratories | 102,845 | 18.32 | 33,741 | 16.73% | 5,725 | 45.58 |
| Cipla | 99,317 | 21.81 | 28,410 | 7.12% | 5,291 | 40.75 |
| Zydus Life Science | 92,111 | 18.06 | 23,511 | 18.55% | 4,615 | 57.32 |
| Mankind Pharma | 85,822 | 47.03 | 12,744 | 20.90% | 2,007 | 51.63 |
| Aurobindo Pharma | 78,373 | 22.33 | 32,346 | 9.43% | 3,484 | 65.82 |
| Alkem Laboratories | 65,043 | 26.50 | 13,458 | 3.70% | 2,216 | 53.68 |
Amrutanjan Health Care Company Announcements - News Screener
Screen AMRUTANJAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-18 | Intimation Of Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations). | - |
| 2026-03-18 | Intimation Of Under Regulation 30 Read With Clause 20 Of Para A Of Part A Of Schedule Ill Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) | - |
| 2026-02-04 | Investor Presentation For The Quarter And Nine Months Ended 31St December 2025 | - |
| 2026-02-03 | Record Date For The Second Interim Dividend Is 7 February 2026 | - |
| 2026-02-03 | Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-01-28 | Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results With The Limited Review Report For The Quarter And Nine Months Ended On 31St December 2025 | - |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-19 | Closure of Trading Window | - |
| 2025-11-11 | Investor Presentation For The Quarter Ended 30Th September 2025 | - |
| 2025-11-10 | Record Date For The First Interim Dividend Is 18 November 2025. | - |
| 2025-11-10 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | - |
| 2025-11-04 | Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Along With The Limited Review Report For The Quarter Ended 30Th September 2025 And Declaration Of The 1St Interim Dividend | - |
| 2025-10-18 | Disclosure Under Regulation 30 Of SEBI LODR 2015 | - |
| 2025-10-14 | Product Launch | - |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-09-26 | Closure of Trading Window | - |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |